Alkaline phosphatase equal or less than 1.5 times the upper limit of normal (ULN)
AST (SGOT), ALT (SGPT) and Alkaline phosphatase 2.5 times upper limit of normal (if liver metastases are present, then 5 x ULN is allowed)
Within 30 days prior to enrollment: Alkaline phosphatase equal or less than 1.5 times the upper limit of normal (ULN)
Alkaline phosphatase =< 4 times the upper limit of normal (unless clinically considered to be related to liver involvement with leukemia)
Alkaline phosphatase =< 2.5 times the upper limit of normal
Alkaline phosphatase (Alk Phos) greater than 2.5 times the upper limit of normal
Alkaline phosphatase =< 2 times upper limit normal
Serum alkaline phosphatase less than 2.5 times the upper limits of normal
Alkaline phosphatase =< 3 times the upper limit of normal
Alkaline phosphatase < 2.5 times the upper limit of normal
Alkaline phosphatase < 5 times the upper limit of normal
Alkaline phosphatase < 2.5 times normal
Serum alkaline phosphatase less than 2.5 times the upper limits of normal within 7 days prior to starting treatment in the absence of liver metastasis; in the presence of liver metastasis serum alkaline phosphatase less than or equal to 5.0 times the upper limits of normal within 7 days prior to starting treatment
Alkaline phosphatase < 4 times the upper limit of institutional normal
Alkaline phosphatase must be no more than 2.5 times upper limit of normal unless due to disease involvement of the liver
Alkaline phosphatase < 5 times upper limit of normal
Performed within 14 days prior to study: Alkaline phosphatase < 3 times the upper limits of the institutional normal
Alkaline phosphatase < 3 times upper limit of institutional normal
Serum alkaline phosphatase < 3 times the upper limit of normal (ULN), unless due to liver or bone involvement by HL; under these circumstances, serum alkaline phosphatase must be < 5 x ULN
Alkaline phosphatase within 3 times the upper limits of normal
Alkaline phosphatase =< 3 times the institutional upper limit of normal
Alkaline phosphatase < 2.5 times institutional upper normal limit (unless due to disease involvement of the liver or bone marrow)
Alkaline phosphatase < 3 times normal
Patient has poor liver function (> 2.5 times normal of alkaline phosphatase [Alk phos]) suggestive of cirrhosis or steatohepatitis
Alkaline phosphatase =< 2.5 times upper limit of normal (unless due to disease involvement of the liver or bone marrow)
Alkaline phosphatase > 2.5 times upper normal limit (unless due to chronic GVHD)
Alkaline phosphatase =< 2.5 times upper limit of normal
Alkaline phosphatase less than 10 times the upper limit of normal (unless due to active myositis)
Alkaline phosphatase < 3 times the upper limit of laboratory normal
Alkaline phosphatase =< 3 times upper limit of laboratory normal
Alkaline phosphatase =< 5.0 times the upper limit of normal unless hepatic dysfunction is related to liver involvement with disease
Alkaline phosphatase < 2.5 times the upper limit of normal; in patients with liver metastasis, liver function tests should be < 5 times the upper limit of normal
Alkaline phosphatase (hepatic) > 3 times the upper normal limit
Serum alkaline phosphatase less than 2.5 times the upper limits of normal
Alkaline phosphatase (hepatic) > 3 times the upper normal limit
Alk phosphatase =< 3 times institutional upper limit of normal
Alkaline phosphatase < 3 times the upper limit of normal (alkaline phosphatase and aspartate aminotransferase [AST] cannot both exceed the upper limit of normal)
AST < 3 times upper limit of normal (alkaline phosphatase and AST cannot both exceed the upper limit of normal)
Alkaline phosphatase (ALP) must be < 2 times the upper limit of normal
Alkaline phosphatase (ALK phos) less than 4.0 times below or above the upper or lower limit range
Alkaline phosphatase (ALK phos) less than 4.0 times below or above the upper or lower limit range
Alkaline phosphatase =< 2 times the upper limit of normal